MSKCC
Memorial Sloan Kettering Cancer Center Portfolio holdings
AUM
$24.6M
This Quarter Return
-14.79%
1 Year Return
+10.16%
3 Year Return
-15.77%
5 Year Return
–
10 Year Return
–
AUM
$162M
AUM Growth
+$162M
(-31%)
Cap. Flow
-$38.6M
Cap. Flow
% of AUM
-23.8%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Royalty Pharma
RPRX
|
$38.6M |
Sector Composition
| 1 | Healthcare | 85.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Royalty Pharma
RPRX
$15.6B
| $117M | 72.07% | 2,680,644 -885,243 | -25% | -$38.6M |
|
2
VanEck Gold Miners ETF
GDX
$19B
| $24M | 14.79% | 738,500 | – | – |
|
3
Oric Pharmaceuticals
ORIC
$994M
| $14.8M | 9.09% | 602,272 | – | – |
|
4
Y-mAbs Therapeutics
YMAB
$388M
| $6.56M | 4.04% | 216,916 | – | – |
|